文献速递心血管外周血管介入CT

低对比剂剂量双能CT在肾功能受损患者经导管主动脉瓣置换术前评估中的诊断效能与安全性

Diagnostic Efficacy and Safety of Low-Contrast-Dose Dual-Energy CT in Patients With Renal Impairment Undergoing Transcatheter Aortic Valve Replacement.
PubMed 文献 · Korean J Radiol · 2024-01-01

本研究纳入54例肾功能减退的连续患者,在经导管主动脉瓣置换术前采用30 mL对比剂行双源双能CT,重建40 keV、50 keV单能图像与常规120 kVp图像。50 keV图像血管衰减和对比噪声比优于常规CT且信噪比相似,主动脉瓣环测量观察者间可靠性更高,全部患者植入装置尺寸与CT测量值匹配,手术成功率92.6%,无患者在CT后48–72小时内血清肌酐升高≥基线1.5倍。作者认为50 keV低对比剂剂量成像可用于肾功能受损患者的术前精确评估。

要点

  • 肾功能受损患者行TAVR术前双能CT,30 mL对比剂、50 keV单能图像即可满足诊断质量。
  • 50 keV图像主动脉瓣环测量观察者间ICC面积0.98、周长0.97,均高于常规CT的0.90、0.95。
  • 全部患者植入装置尺寸与CT测量值匹配,手术成功率92.6%,未见CT后48–72小时血清肌酐升高≥基线1.5倍。

核心结论

  • 50 keV重建的低对比剂剂量双能CT可实现精确的TAVR术前评估,图像质量改善且对比剂后急性肾损伤风险极小,作者认为该方法可能是肾功能受损患者TAVR术前评估的有效且安全的选择。

研究设计与样本

  • 单中心连续病例研究,纳入2022年6月至2023年3月间54例肾功能减退患者(女26例、男38例,年龄81.9±7.3岁),行30 mL对比剂的术前双源双能CT,重建40 keV、50 keV单能图像与常规120 kVp图像,比较主观质量评分、血管衰减、CNR与SNR,并以ICC和Bland-Altman分析评估主动脉瓣环测量的观察者间可靠性,同时评估手术结局与对比剂后急性肾损伤发生率。

关键影像表现/征象

  • 50 keV单能图像血管衰减与CNR均优于常规CT(P < 0.001),信噪比与常规CT相似。
  • 单能图像在全部患者中达到诊断质量。
  • 主动脉瓣环测量观察者间ICC:50 keV图像面积0.98、周长0.97,常规CT面积0.90、周长0.95。
  • 95%一致性界限宽度:50 keV图像面积0.63 cm²、周长5.78 mm,常规CT面积0.92 cm²、周长8.50 mm。

诊断标准与关键数值

  • 50 keV图像与常规CT比较:血管衰减和CNR的P < 0.001(均为50 keV更优),SNR相似。
  • 主动脉瓣环面积观察者间ICC为0.98(50 keV)vs. 0.90(常规CT),周长ICC为0.97 vs. 0.95。
  • 主动脉瓣环面积95%一致性界限宽度为0.63 cm²(50 keV)vs. 0.92 cm²(常规CT),周长为5.78 mm vs. 8.50 mm。
  • 全部患者植入装置尺寸与CT测量值匹配,手术成功率92.6%。
  • 无患者在CT后48–72小时内血清肌酐升高≥基线1.5倍。

临床应用与阅片要点

  • 对肾功能受损拟行TAVR的患者,可采用30 mL对比剂的低剂量双能CT方案,并以50 keV单能图像进行瓣环测量与术前评估。
  • 50 keV图像在瓣环面积与周长测量上观察者间一致性高于常规120 kVp图像,一致性界限更窄。
  • 本组中1例患者因肾功能逐渐恶化导致手术延迟,原文未说明该例与对比剂的关系。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study aimed to evaluate the diagnostic efficacy and safety of low-contrast-dose, dual-source dual-energy CT before transcatheter aortic valve replacement (TAVR) in patients with compromised renal function.

MATERIALS AND METHODS: A total of 54 consecutive patients (female:male, 26:38; 81.9 ± 7.3 years) with reduced renal function underwent pre-TAVR dual-energy CT with a 30-mL contrast agent between June 2022 and March 2023. Monochromatic (40- and 50-keV) and conventional (120-kVp) images were reconstructed and analyzed. The subjective quality score, vascular attenuation, contrast-to-noise ratio (CNR), and signal-to-noise ratio (SNR) were compared among the imaging techniques using the Friedman test and post-hoc analysis. Interobserver reliability for aortic annular measurement was assessed using the intraclass correlation coefficient (ICC) and Bland-Altman analysis. The procedural outcomes and incidence of post-contrast acute kidney injury (AKI) were assessed.

RESULTS: Monochromatic images achieved diagnostic quality in all patients. The 50-keV images achieved superior vascular attenuation and CNR (P < 0.001 in all) while maintaining a similar SNR compared to conventional CT. For aortic annular measurement, the 50-keV images showed higher interobserver reliability compared to conventional CT: ICC, 0.98 vs. 0.90 for area and 0.97 vs. 0.95 for perimeter; 95% limits of agreement width, 0.63 cm² vs. 0.92 cm² for area and 5.78 mm vs. 8.50 mm for perimeter. The size of the implanted device matched CT-measured values in all patients, achieving a procedural success rate of 92.6%. No patient experienced a serum creatinine increase of ≥ 1.5 times baseline in the 48-72 hours following CT. However, one patient had a procedural delay due to gradual renal function deterioration.

CONCLUSION: Low-contrast-dose imaging with 50-keV reconstruction enables precise pre-TAVR evaluation with improved image quality and minimal risk of post-contrast AKI. This approach may be an effective and safe option for pre-TAVR evaluation in patients with compromised renal function.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Chang S, Jung JI, Beck KS, et al. Diagnostic Efficacy and Safety of Low-Contrast-Dose Dual-Energy CT in Patients With Renal Impairment Undergoing Transcatheter Aortic Valve Replacement. Korean J Radiol. 2024. PMID: 38942457. doi:10.3348/kjr.2023.1207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。